We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Huazhu Hotels Group
HTHT
$12.4B
| $59.6M | 0.21% |
9,075,728
+18,604
| +0.2% | +$117K |
|
127
Cardinal Health
CAH
$53.4B
| $59.6M | 0.21% |
738,020
+75,365
| +11% | +$5.95M |
|
128
Altria Group
MO
$122B
| $59.5M | 0.21% |
1,207,445
-10,707
| -0.9% | -$522K |
|
|
GRFS
129
Grifois
GRFS
$5.16B
| $57.9M | 0.2% |
3,408,470
-118,550
| -3% | -$2.04M |
|
130
Simon Property Group
SPG
$74.5B
| $57.3M | 0.2% |
314,460
-383
| -0.1% | -$67.9K |
|
131
Exelon
EXC
$48.6B
| $57.1M | 0.2% |
+2,159,401
| New | +$55.4M |
|
|
CXO
132
DELISTED
CONCHO RESOURCES INC.
CXO
| $56.9M | 0.2% |
570,060
+199,871
| +54% | +$21M |
|
133
Johnson Controls International
JCI
$87.5B
| $55.3M | 0.19% |
1,091,574
-260,112
| -19% | -$12.7M |
|
134
JB Hunt Transport Services
JBHT
$27.1B
| $53.7M | 0.19% |
+637,116
| New | +$50.7M |
|
135
Home Depot
HD
$332B
| $53.2M | 0.18% |
506,768
+22,803
| +5% | +$2.22M |
|
136
SLB Ltd
SLB
$77.8B
| $51.7M | 0.18% |
604,934
+120,192
| +25% | +$11.1M |
|
137
Parker-Hannifin
PH
$125B
| $50.1M | 0.17% |
+388,480
| New | +$47.7M |
|
|
RHT
138
DELISTED
Red Hat Inc
RHT
| $49.1M | 0.17% |
710,354
+355,335
| +100% | +$21.5M |
|
|
SWI
139
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $48.9M | 0.17% |
982,053
+19,751
| +2% | +$941K |
|
140
Truist Financial
TFC
$63.2B
| $48.6M | 0.17% |
1,248,468
-348,393
| -22% | -$13.1M |
|
141
L3Harris
LHX
$55.9B
| $47.5M | 0.16% |
+661,412
| New | +$45.8M |
|
142
Target
TGT
$62.1B
| $47.1M | 0.16% |
620,179
+267,607
| +76% | +$18.1M |
|
143
Biogen
BIIB
$29.9B
| $47M | 0.16% |
138,390
+59,563
| +76% | +$19.3M |
|
|
TFM
144
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $46.5M | 0.16% |
1,127,569
+457,624
| +68% | +$17.4M |
|
145
American International
AIG
$41.9B
| $46M | 0.16% |
820,383
-1,137,064
| -58% | -$61M |
|
|
HES
146
DELISTED
Hess
HES
| $45.6M | 0.16% |
617,818
+12,922
| +2% | +$1.02M |
|
147
Ultragenyx Pharmaceutical
RARE
$2.65B
| $45.4M | 0.16% |
1,034,028
| – | – |
|
148
Ryman Hospitality Properties
RHP
$8.4B
| $44.2M | 0.15% |
838,459
-41,053
| -5% | -$2.05M |
|
149
Ally Financial
ALLY
$13.1B
| $44.2M | 0.15% |
1,870,500
+590,000
| +46% | +$13.3M |
|
|
COV
150
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $43.5M | 0.15% |
425,516
-76,014
| -15% | -$7.29M |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.